Well Referenced

Tag: SGLT2 Inhibitors

Weight Beneficial Treatments for Type 2 Diabetes

This review examines the impact of “weight-friendly” pharmacotherapies in the management of type 2 diabetes mellitus (T2DM), emphasizing the importance of considering the weight effects of different treatment regimens. It highlights that certain antidiabetic agents, such as metformin, GLP-1 receptor agonists, and SGLT2 inhibitors, are associated with weight neutrality or

Read More »
June 26, 2025 No Comments

A Review on the Relationship between SGLT2 Inhibitors and Cancer

This review examines the potential association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and cancer risk. Early clinical trials of dapagliflozin indicated an imbalance in reported cases of breast and bladder cancer, raising safety concerns. However, these findings lacked statistical significance and may be attributed to early cancer detection rather than

Read More »
June 26, 2025 No Comments